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MISCELLANEOUS
INTRODUCTION
The clinician has three aims in the preoperative evaluation: to determine the risk of preoperative complications, to 
decrease the risk of perioperative complications, and to eliminate the risk factors in patients who have a risk of complica-
tions in the postoperative period. For this purpose, an accurate preoperative evaluation would allow the patient to be 
operated on with minimum risk. 
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1. PERIOPERATIVE RESPIRATORY PHYSIOLOGY 
Respiratory physiology in patients undergoing surgery can be 
investigated under two topics:
1) Anesthesia-Related Changes in Pulmonary Functions 
Inhaled or intravenous anesthetic agents cause a reduction in 
functional residual capacity (FRC) by up to 20% by means of 
decreasing respiratory muscle tone. The reasons for the 
decrease in FRC include pain, abdominal distension, pulmo-
nary venous congestion, and posture [1]. Reduction in func-
tional residual capacity results in atelectasis. Atelectasis 
leads to ventilation/perfusion imbalance. A reduction in all 
lung volume components during anesthesia leads to a 
decrease in airway diameter and an increase in airway resis-
tance. Decreased mucociliary clearance is caused by low 
inspired air temperature, inflation of the endotracheal tube 
cuff, and use of anesthetic agents, like halothane. All of these 
changes contribute to the development of hypoxia. Attention 
should be paid to the inhalation of a high concentration of 
oxygen during anesthesia. High levels of oxygen cause respi-
ratory depression by inhibiting the respiratory center response 
to hypoxia. 
Anesthesia-related hypercarbia may also be seen. The mech-
anisms of hypercarbia development include increased dead 
space ventilation with the anesthesia devices used, along 
with hypoventilation and an increase in oxygen consump-
tion due to catecholamine release during superficial anesthe-
sia. The elevation of partial pressure of carbon dioxide in 
arterial blood (PaCO2) to high levels causes respiratory 
depression. It increases intracranial pressure, leading to cere-
bral vasodilation. Hypercarbia, which develops during gen-
eral anesthesia, particularly during halothane use, causes 
serious arrhythmias. In addition to hypercarbia, hypocarbia 
may be seen as well during anesthesia; if the patient is hyper-
ventilated, hypothermia, hypotension, and hypocarbia may 
be encountered during deep anesthesia. 
2) Surgical Procedure-Related Changes in Pulmonary 
Functions 
The site, duration, and technique of surgical intervention 
have different effects on respiratory functions. During upper 
abdominal and thoracic surgeries, lung volumes decrease, 
leading to atelectasis and hypoxia [2]. The impairment in 
pulmonary functions is more pronounced in cardiac surgery. 
After pulmonary resection, a loss of 30% can be observed in 
forced expiratory volume in 1 second (FEV1) and forced vital 
capacity (FVC) in the early postoperative period [3].
2. PATIENT-RELATED RISK FACTORS
1) Age 
In general, the incidence of postoperative complications 
(POPCs) was determined to be higher in cases at and over 
the age of 65 years [4,5]. 
2) Chronic Obstructive Pulmonary Disease
The incidence of POPCs increases approximately twice in 
the presence of COPD; however, there is no pulmonary func-
tion parameter that poses an absolute contraindication for 
surgery [6,7]. 
3) Asthma
Asthma is not a serious risk factor for pulmonary complica-
tions. The incidence of complications was determined to be 
higher in elder patients and in patients with uncontrolled 
asthma [8].
Özkan et al. Summary of Consensus Report on Preoperative Evaluation
44
4) Smoking
The risk of complications is determined to be 1.4-4.3 times 
higher in smokers [9,10]. There is no definite consensus on 
the time of smoking cessation. In general, smoking cessation 
is recommended 8 weeks before surgery. 
5) General Health Status
General health status is usually evaluated using the American 
Society of Anesthesiologists (ASA) classification. There is a 
good correlation between ASA classification and POPCs. 
While the odds ratio is 7.1 in ASA Class II and higher 
patients, it was found to be 3.34 in ASA Class I patients [5]. 
The Cardiopulmonary Risk Index (CPRI), made up of the 
Goldman Cardiac Risk Index and Pulmonary Risk Index, is 
also used, along with this classification (Table 1). 
Complications were determined to be 17 times higher in 
patients with a cardiopulmonary risk index higher than 4 as 
compared to patients with a cardiopulmonary risk index 
lower than 4 [11]. 
6) Obesity
It has been demonstrated that complication rates are not 
higher, even in morbidly obese patients, than in healthy indi-
viduals [12,13]. 
7) Obstructive Sleep Apnea 
Obstructive sleep apnea (OSA) is a serious risk factor for 
POPCS [14]. 
8) Pulmonary Hypertension 
Patients with pulmonary hypertension (PH) undergoing non-
cardiac surgery (right ventricular systolic pressure >35 mm 
Hg) have higher risks for postoperative congestive heart fail-
ure, cardiac ischemic events, arrhythmias, stroke, respiratory 
failure (the most common cause of morbidity), hepatic dys-
function, renal dysfunction, or the need for postoperative 
positive inotropic or vasopressor agent [11]. 
9) Heart failure
The odds ratio for POPCs was found to be 2.93 (95% CI 
1.02-8.43) in patients with heart failure [15]. 
10) Metabolic Condition
Both low albumin (<3 g/dL) (odds ratio=2.53) and high BUN 
(>30 mg/dL) (odds ratio=2.29) were determined to be sig-
nificant indicators of pulmonary complications [16].
11) Upper Respiratory Tract Infection
Postponing elective surgery would be appropriate in patients 
with URTI. 
3. RISK FACTORS ASSOCIATED WITH SURGICAL 
INTERVENTION 
1) Site and Type of Surgery
Upper abdominal and thoracic surgeries cause significant 
impairments in pulmonary functions. The rate of postopera-
tive complications is inversely proportional to the distance of 
the incision to the diaphragm [17] but varies depending on 
the surgical intervention. The rate is very high in esophageal 
surgery, and it was found to be 3.24 times higher in those 
operated on due to malignant tumor [18,19]. The type of in-
cision, as well as the type of surgery, is important in pre-
dicting the development of POPCs. It has been reported that 
laparotomy performed through a transverse incision causes 
pulmonary complications less frequently [20]. 
2) Elective/Emergency Surgery
Emergency surgery is an important marker in estimating the 
risk of mortality; the odds ratio was reported to be 2.21 for 
emergency surgery [15,21].
3) Surgical Technique
Laparoscopic methods are recommended, as they reduce 
postoperative morbidity and shorten postoperative hospital 
stay [22].
4) Duration of Surgery
The risk of POPCs is 1.6-5.2-fold higher in surgeries that last 
for more than 3-4 hours [23]. 
5) Type of Anesthesia/Type and Duration of Neuromuscular 
Blockade 
Epidural anesthesia allows better suppression of surgical 
stress, maintains more stable cardiovascular hemodynam-
ics, and provides better peripheral vascular circulation and 
better postoperative pain control [24]. Epidural anesthesia 
performed in the upper regions of the spinal column (T1-T5 
dermatomes) causes more significant impairments in pulmo-
nary functions [25]. 
The agents that are used for anesthesia affect pulmonary 
functions. The risk of POPCs was found to be 3 times higher 
Table 1. Cardiopulmonary risk index [2]
Variable  Points
Cardiac risk index (CRI)
Age over 70 years 5
Right heart failure (S3, jugular venous distension,  11 
left ventricular ejection fraction <40% 
Myocardial infarction within the last 6 months  10
Premature ventricular contractions more than 5/minute  7
Premature atrial contractions or rhythm other than  7 
sinus rhythm on preoperative ECG  
Significant aortic stenosis  3
Impaired general health status  3
Grading of CRI (Total 4 points) 
1=3-5 
2=6-12 
3=12-25
4≥25
Pulmonary risk index (PRI)
Obesity (body mass index >27 kg/m2) 1
Smoking within the last 8 weeks  1
Diffuse rhonchi or rales 5 days prior to the surgery  1
Productive cough for the last 5 days  1
FEV1/FVC <70% 1
PaCO2 >45 mm Hg 1
PRI score 6 points  
CPRI score=CRI+PRI (10 points) 
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in patients receiving long-acting neuromuscular blockers 
(pancuronium) as compared to those receiving short-acting 
neuromuscular blockers (atracurium, vecuronium) [26]. The 
duration of anesthesia, as well as the agents used in anesthe-
sia, is important for the development of POPCs. It was stated 
that the duration of anesthesia was observed to be longer in 
patients that developed postoperative complications (300 
minutes vs. 198 minutes) [27].
4. PREOPERATIVE PULMONARY EVALUATION 
1) Anamnesis and Physical Examination 
Pulmonary symptoms that have to be questioned include 
dyspnea, wheezing, chest pain, hemoptysis, cough, and spu-
tum. In addition, age, history of smoking and drug use, occu-
pational exposure, immobilization, and concomitant diseas-
es also need to be questioned. 
The physical examination should focus on information obtained 
from the anamnesis. All patients should undergo a cardiovas-
cular and respiratory system examination, and underlying dis-
ease should be investigated in the presence of signs of exces-
sive secretion, obstruction, emphysema and respiratory failure, 
hypertension, dysrhythmia, and tachycardia. The presence of 
pathology during the preoperative respiratory system examina-
tion increases the risk of POPCs by 5.8-fold [28].
2) Chest X-ray
Chest x-ray is recommended in those with cardiopulmonary 
disease, those over the age of 50 years, and those who 
undergo upper abdominal, thoracic, or abdominal aortic 
aneurism surgery [15]. 
3) Arterial Blood Gasses
Arterial blood gas analysis is recommended in patients who 
undergo abdominal, thoracic, or cardiovascular surgery in 
the presence of dyspnea or a history of smoking [29]. 
4) Pulmonary Function Test
The superiority of spirometric values to anamnesis and physi-
cal examination has not been shown [15]. Spirometry is indi-
cated in patients who undergo lung resection surgery in order 
to determine the postoperative FEV1 and the suitability for 
resection. Moreover, spirometry is indicated in all patients 
over the age of 60 years; with ≥20 pack-years of smoking his-
tory; with known pulmonary disease, respiratory system symp-
toms, and complaint of shortness of breath, together with a 
history of smoking; and in patients scheduled for upper 
abdominal or long-lasting lower abdominal surgery.
5) Cardiopulmonary Exercise Test 
Cardiopulmonary exercise testing might be beneficial in 
elderly patients with cardiac or pulmonary disease in esti-
mating whether the patient can tolerate surgery [30]. Routine 
use is not recommended, except for thorax surgery. 
6) Pulmonary Risk Indexes
The rate of postoperative complications was found to be 22 
times higher in those with a cardiopulmonary risk index 
score higher than 4 as compared to those with a cardiopul-
monary risk index score lower than 4. It was observed that 
complications do not develop in those with a cardiopulmo-
nary risk index score ≤2 [31]. 
5. PREOPERATIVE EVALUATION IN SPECIAL SITUATIONS 
1) Asthma 
The first thing to do in the preoperative evaluation is to assess 
whether the patient’s asthma is under control or not. It is not 
necessary to perform pulmonary function tests in an asymp-
tomatic patient with controlled asthma. Control of arterial 
blood gases during attacks is important.
The drugs received by the patient are reviewed, and the pul-
monary functions of the patient are aimed to be brought to 
baseline or close to it. In newly diagnosed or non-compliant 
patients, 40 mg of oral methyl prednisolone may be given for 
5 days prior to surgery [32]. Prophylactic systemic steroid 
therapy is also recommended in patients with a history of 
systemic steroid therapy within the last 6 months [33]. The 
recommended inhaled anesthetic agent is sevoflurane [34]. 
A laryngeal mask airway may be preferred, since tracheal 
intubation can lead to a reversible increase in airway resis-
tance [35]. The patient should be hydrated over the course of 
the surgery, keeping in mind that overhydration might lead to 
pulmonary congestion and bronchospasm.
2) Chronic Obstructive Pulmonary Disease 
Things to do in the preoperative period in the case of COPD 
include smoking cessation at least 8 weeks prior to surgery, 
correction of mineral and electrolyte deficiency, providing 
additional nutrition in those with serious malnutrition, com-
mencing bronchodilators in those with airway obstruction, 
and starting patient education, including lung expansion 
maneuvers. In COPD patients, initiation of bronchodilator 
inhalation as premedication, limiting the duration of surgery 
to 3 hours, preferring less invasive interventions if possible, 
and using spinal-epidural or troncular anesthesia are recom-
mended. In the postoperative period, extubation and sponta-
neous ventilation should be provided as soon as possible, 
inhaled bronchodilators should be used, deep breathing 
exercises or incentive spirometry (IS) should be performed, 
bronchial secretions should be removed, and epidural or 
troncular analgesia should be used [36].
3) Obstructive Sleep Apnea Syndrome 
In the preoperative period, patients with suspected OSAS 
should be either referred to surgery by considering them at 
“high risk for OSAS” or transferred to a sleep center for fur-
ther analysis and treatment, based on the urgency of the 
surgery. The patients that have been diagnosed with OSAS 
via polysomnography are usually treated with preoperative 
CPAP [37]. Regional anesthesia can be preferred to general 
anesthesia in patients with OSAS. Short-acting agents should 
be preferred for ideal general anesthesia. Emergency airway 
intervention tools should be easily accessible. The most 
important postoperative problems are hypoxemia and hyper-
capnia. Therefore, performing CPAP in the early period 
would be beneficial [38].
4) Lung Transplantation
Candidates of transplantation need to be in adequate 
physical condition to tolerate the expected perioperative 
and postoperative complications and the toxicity of immu-
nosuppressive drugs, in addition to having the psychosocial 
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power and support necessary to adopt major changes in 
their lifestyles that transplantation brings along. They are 
not supposed to have uncontrollable or untreatable serious 
cardiac, liver, kidney, and bone marrow, problems [39]. The 
patient should have a certain level of exercise and rehabili-
tation potential before transplantation. A body mass index 
over 30 is considered a relative contraindication for trans-
plantation [40]. 
6. PREOPERATIVE AND POSTOPERATIVE RISK REDUCTION 
STRATEGIES 
1) Smoking Cessation
The idea of smoking cessation at least 8 weeks before surgery 
to reduce the rate of complications in patients undergoing 
elective surgery has been supported by many studies [41,42]. 
Medical therapy (nicotine replacement therapy, bupropion, 
or varenicline) may be recommended for smoking cessation 
in patients with a history of smoking [43]. Initiation of incen-
tive spirometry in the preoperative period and bronchodila-
tors in suitable cases, based on PFT, may be recommended.
2) Chronic Obstructive Pulmonary Disease and Asthma 
Control 
Appropriate bronchodilators (preferably a long-acting beta-2 
agonist, long-acting anticholinergic, and theophylline) and 
inhaled corticosteroid therapies need to be given to COPD 
cases, as recommended in the guidelines. Nevertheless, 
short-term oral corticosteroids may be added to the treatment 
in COPD cases that have moderate-severe obstruction in the 
spirometry. Breathing exercises and respiratory physiothera-
py should be performed in suitable patients. It may be appro-
priate for patients with moderate or severe impairments in 
pulmonary function testing to switch to nebulizer treatment 
from the inhaled form in their on-going treatment before 
surgery [44]. The surgery is postponed in the event of pulmo-
nary infection or acute exacerbation of COPD. Treatment for 
respiratory tract infection should be performed with an anti-
biotic of the appropriate spectrum for the appropriate time. 
Oxygen should be given if the patient has hypoxemia, and 
non-invasive mechanical ventilation should be performed if 
PaCO2 is high, particularly in patients in type 2 respiratory 
failure [45]. 
Optimal treatment should be arranged to keep FEV1 or peak 
flow rate (PEF) over 80% in asthmatic patients who undergo 
elective surgery. Inhaled bronchodilator use in asthmatic 
patients should continue until just before the surgery. It is 
convenient for patients with asthma that is not under ade-
quate control to switch from the inhaled form to the the 
nebule form of the drug that they have been receiving 1-2 
days before surgery [44]. In addition, intravenous steroids 
reduce perioperative bronchospasm in such patients [46]. In 
asthmatic patients with an FEV1 of less than 80%, 0.5-1 mg/
kg prednisone should be given for 5-7 days preoperatively 
and discontinued on the first postoperative day. If the patient 
has a history of systemic steroid use for longer than 2 weeks 
within the last 6 months or on-going systemic steroid use, 
100 mg hydrocortisone should be initiated at 8-hour inter-
vals 24 hours before surgery and then continued by gradu-
ally decreasing the dose until oral therapy is initiated [45]. 
3) Preoperative Antibiotic and Mucolytic Therapy 
Preoperative antibiotic use is not beneficial for the preven-
tion of pneumonia in patients with stable COPD or con-
trolled asthma, unless other disorders, such as acute bron-
chitis, bronchiectasis, or immune deficiency, are present. 
Elective surgery should be cancelled until the completion of 
treatment in patients with purulent sputum or a change in 
character sputum and in those having an underlying disease, 
like COPD. Regular treatment with mucolytic agents and 
fluid intake may be recommended in patients with under-
lying hypersecretory diseases, such as chronic bronchitis or 
bronchiectasis. N-acetylcysteine can be given regularly for 
the excretion of postoperative secretions more easily [44].
4) Patient Education
If possible, patients should be educated 2-3 days before sur-
gery. The importance of coughing, respiratory physiology, and 
patient compliance during weaning from the ventilator should 
be explained to the patient. In patients with hypersecretion 
before surgery, secretion drainage should be provided by 
teaching the techniques, including postural drainage, vibration, 
percussion, coughing, flutter use, huffing, and humidification. 
Rapid mobilization should be provided after the surgery. [47].
5) Prophylaxis for Deep Vein Thrombosis and Pulmonary 
Thromboembolism 
Prophylactic interventions to prevent postoperative deep 
vein thrombosis (DVT) include leg elevation; use of elastic 
bandages, compression socks, and pneumatic compression 
devices; lower extremity exercises; and early mobilization. 
Moreover, attention should be paid to bed sheet-cloth folds, 
cross-legged positioning, catheter contacts, and compres-
sion, which impair blood circulation. 
The agents that are most commonly used in venous thrombo-
embolism (VTE) prophylaxis include: 
Unfractionated heparin: It is recommended to be initiated at 
a dose of 5000 IU 2 hours before surgery and at a dose of 
5000 IU at 12-hour intervals thereafter. 
Low-molecular-weight heparin and fondaparinux: Enoxaparin 
is recommended to be started just before surgery and then 
used at 12-hour intervals at a dose of 40 mg; dalteparin is 
recommended to be used at a dose of 500 IU/day, nadroparin 
is recommended to be used at a dose of 3500 IU/day; and 
fondaparinux is recommended to be used at a dose of 2.5 mg/
day via subcutaneous route [48].
6) Pulmonary Rehabilitation and Breathing Exercises 
a) Pulmonary rehabilitation in the preoperative period 
Preoperative pulmonary rehabilitation should include chest 
physiotherapy, an aerobic exercise program, and smoking 
cessation [49]. In general, the exercise program that is rec-
ommended in the preoperative period consists of multi-
dimensional aerobic and strengthening exercises, including 
lower and upper extremity exercises, that are performed 2-3 
times weekly for 6-8 weeks. 
b) Pulmonary rehabilitation in the postoperative period 
Early mobilization, along with breathing control, to provide 
normal FRC and alveolar ventilation should be started in the 47
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early postoperative period unless there is any condition that 
might be a contraindication. Moreover, coughing and deep 
breathing exercises should be performed hourly to increase 
alveolar volume and regulate the distribution of ventilation 
[50]. Postoperative hypoxemia and atelectasis can be pre-
vented by incentive spirometry devices, which enable effec-
tive coughing by increasing inspiratory capacity. Incentive 
spirometry is particularly recommended in patients who are 
unable to perform breathing exercises and have a risk of atel-
ectasis. It has been proven that CPAP prevents atelectasis and 
pneumonia development more than deep breathing exercis-
es, incentive spirometry, and coughing techniques [51]. 
7. POSTOPERATIVE COMPLICATIONS AND RISK 
REDUCTION STRATEGIES
1) Lung Expansion Maneuvers 
Lung expansion maneuvers consist of incentive spirometry, 
deep breathing exercises, postural drainage, percussion/
vibration, mobilization, and positive airway pressure thera-
pies, such as CPAP, bi-level positive airway pressure (BiPAP), 
and intermittent positive pressure breathing (IPPB). 
Implementation of these methods should be decided on an 
individual patient basis, considering accessibility, cost, and 
experience regarding the method that would be preferred in 
moderate- and high-risk patients for postoperative pulmo-
nary complications. CPAP could be the primary method in 
high-risk patients and particularly in patients who can not 
adhere to other methods. 
2) Pain control
Postoperative epidural and “patient-controlled analgesia” 
(PCA) and intravenous analgesia are more successful than 
conventional opioid therapy in preventing postoperative pul-
monary complications [52].
3) Early Mobilization Protocol
The early mobilization protocol consists of shorter preopera-
tive fasting, patient-controlled epidural analgesia via epi-
dural catheter, starting enteral feeding on the night of surgery, 
and patient mobilization. 
4) Glycemic Control
Providing glycemic control in the medical and surgical 
patient population is associated with a decrease in the dura-
tion of mechanical ventilation. However, the effect of glyce-
mic control on postoperative complications is not known. 
What the optimal blood glucose level should be in effective 
glycemic control is another issue being discussed [53].
5) Selective Nasogastric Decompression
It is thought that bowel function returns to normal more rap-
idly and that the risk of aspiration is reduced via routine 
nasogastric (NG) decompression after abdominal surgery. 
6) Nutritional Support 
The presence of hypoalbuminemia and malnutrition enhanc-
es postoperative complications. It has been demonstrated 
that total parenteral nutrition (TPN) does not provide any 
additional contribution as compared to total enteral nutri-
tion (TEN) except for the presence of severe malnutrition 
(>10% weight loss in 6 months) or prolonged inadequate 
enteral nutrition (longer than 10-14 days) [52]. Further stud-
ies that evaluate the effects of enteral formulas, which are 
considered to strengthen the immune system, are needed. 
Intestinal villus atrophy and related bacterial translocation 
from the intestinal mucosa and sepsis might develop due to 
inadequate oral intake after surgery. Starting oral intake 
immediately after surgery should be targeted to prevent 
these complications. 
8. APPROACH IN THORACIC SURGERY 
1) Preoperative Pulmonary Functions 
It was observed that postoperative mortality was 40% in 
cases having a maximum voluntary ventilation (MVV) of less 
than 50% and an FVC of less than 70% [54]. The fact that 
maximum voluntary ventilation is an individual effort-depen-
dent test prevents its use in the routine examination. Forced 
expiratory volume in 1 second has become the primary spi-
rometric measurement in the preoperative evaluation. 
Current guidelines report that cases with an FEV1 of 2 L (or 
>80% of predicted) could tolerate pneumonectomy and that 
those with an FEV1 of 1.5 L could tolerate lobectomy [55,56]. 
Nevertheless, measuring DLCO levels has also been recom-
mended in patients with severe exercise dyspnea or intersti-
tial lung disease. It was reported that further physiological 
tests are not necessary in cases with a preoperative FEV1 and 
DLCO >80% of the predicted values for each [56]. 
2) Predicted Postoperative Pulmonary Functions 
Postoperative pulmonary function is predicted by determin-
ing perioperative FEV1 or DLCO values and their contribu-
tion to lobar or total function of the whole lung by means of 
quantitative pulmonary perfusion scintigraphy or quantitative 
computed tomography (CT) of the lungs. Alternatively, pre-
dicted postoperative FEV1 can also be calculated by the fol-
lowing formula: 
Predicted postoperative FEV1=preoperative FEV1 X (number of 
remaining lung segments/total number of lung segments) [57]. 
Increased risk for pulmonary resection has been reported in 
those with a postoperative FEV1 and DLCO ≤ 40% than the 
predicted values for each [56]. Preoperative exercise tests are 
recommended for such cases to determine the surgical risk 
level. The 2009 ERS/ESTS guidelines recommend using 30% 
instead of 40% as the cut-off value for predicted postopera-
tive FEV1 and DLCO. Moreover, an evaluation by cardiopul-
monary exercise test before deciding surgery was deemed to 
be necessary [58]. 
3) Arterial Blood Gases
Preoperative baseline PaO2 value is not an important criteri-
on for the development of postoperative complications and 
mortality. Hypercapnia is generally considered an important 
risk factor for pulmonary resection [59].
4) Exercise tests
The use of exercise tests in the preoperative evaluation of 
patients undergoing thoracotomy has recently become a cur-
rent issue. Stair-climbing test is a traditional test that has been 
used for a long time for the evaluation of patients. Although its 
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standardization is thought to be poor, this test enables the iden-
tification of high-risk patients for pulmonary resection [60].
The measurement that best correlates with postoperative 
complications in cardiopulmonary exercise test is the level of 
achieved work, which is measured as VO2max. It was observed 
that cases with a VO2max<10 mL/kg/min have a substantially 
high risk for perioperative complications and mortality [61].
It has been reported that cases with a VO2max<10 mL/kg/min or 
15 mL/kg/min and predicted postoperative FEV1 and DLCO 
values <40% of expected values have a high risk for periop-
erative mortality and cardiopulmonary complications [56]. If 
predicted postoperative FEV1 or DLCO level is <30%, then the 
predicted postoperative VO2max is calculated. If the predicted 
postoperative VO2max is <10 mL/kg/min or <35% of the expect-
ed value, options other than surgery should be preferred. 
Surgery is not absolutely contraindicated when the estimated 
postoperative VO2max is >10 mL/kg/min or >35% of the expect-
ed value. Nevertheless, the patients should clearly understand 
these increased risks while making decisions because of the 
increased risk that might be brought along with low predicted 
postoperative FEV1 and DLCO values [58].
5) Concurrent Volume Reduction Surgery 
This surgery is recommended in cases with a tumor located 
in an emphysematous upper lobe and in those with both the 
predicted postoperative FEV1 and DLCO levels >20% of the 
expected values [56].
6) Cardiovascular Risk
The cases with lung cancer and COPD risk generally have a 
coronary heart disease risk that might require a preoperative 
evaluation. Therefore, a detailed cardiac examination should 
be performed in cases who undergo surgery for lung cancer. 
9. THINGS TO DO WHEN CONSULTATION IS REQUESTED 
FOR THE PATIENT 
Examination for chest diseases begins with a detailed anam-
nesis and physical examination. Laboratory analyses that 
investigate pathological conditions are requested based on 
the anamnesis and physical examination findings. Chest 
x-ray should be considered for high-risk patients over the age 
of 50 years and for patients thought to have cardiac or pul-
monary disease [62]. Pulmonary function test is recom-
mended before all kinds of surgery in patients having dys-
pnea and exercise intolerance. Routine spirometry is not 
recommended for risk assessment in asymptomatic patients 
undergoing surgery other than cardiothoracic surgery [6]. 
Pulmonary risk indexes can be used for the assessment of 
postoperative risks.
1) Multifactorial Risk Index for Postoperative Respiratory 
Failure 
The multifactorial risk index has been defined for the estima-
tion of postoperative respiratory failure (Table 2) [16]. Among 
procedure-related risk factors, the types of surgery and emer-
gency surgery are introduced as the most important predic-
tors. It is not suitable to be used in daily practice, as it is 
complex and contains 28 independent risk factors. 
2) Risk Index for the Estimation of Postoperative Pulmonary 
Complications 
The Canet Risk Index can be used (Table 3) [63]. Being eas-
ily applicable and containing already existing clinical infor-
mation are among the advantages of this index. 
Perioperative therapeutic approaches should be implemented 
to reduce the risk in patients considered to be at moderate risk. 
It is not appropriate to make recommendations on the anes-
thesia technique that is going to be performed. Another issue 
is refraining from the issues that are irrelevant to the proce-
dure. The consulting clinician should evaluate the patient in 
terms of surgery, perioperative risk, and necessity for further 
analysis and intervention. Other issues (patient education, 
immunization, etc.) can be planned after surgery or on admis-
sion to the outpatient clinic. After consultation, some patients 
may ask questions about whether surgery could be performed. 
The patient may be informed about perioperative pulmonary 
complications, stating that the last decision needs to be made 
by the surgeon, together with the patient.
10. PREOPERATIVE EVALUATION IN PEDIATRIC PATIENTS 
WITH CHEST DISEASE 
1) Aim
The aim of the preoperative pulmonary evaluation is to deter-
mine the risk of postoperative pulmonary complications, 
which is approximately 9.6% in children with pulmonary 
problems, and to minimize the potential problems [64]. 
Clinically significant postoperative pulmonary complications 
include atelectasis; infections, like bronchitis and pneumo-
nia; prolonged mechanical ventilation and respiratory fail-
ure; exacerbation of underlying chronic pulmonary disease; 
and bronchospasm [65]. Patient-related risk factors for peri-
operative pulmonary complications include general health 
status, age, upper respiratory tract infection, asthma, chronic 
pulmonary disease, and obstructive sleep apnea syndrome. 
Surgery-related known risk factors include thoracic and 
upper abdominal surgeries and surgical procedures lasting 
longer than 3 hours [4,66].
Table 2. Arozullah respiratory failure risk index [10]
Preoperative risk factors Score 
Type of surgery 
Abdominal aortic aneurysm 27
Thorax 21
Brain surgery, upper abdomen, peripheral vascular surgery 14
Neck  11
Emergency surgery 11
Albumin <3.0 g/dL 9
BUN >30 mg/dL 8
Dependent functional status 7
History of COPD 6
Age  
>70 years 6
60-69 years 4
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2) Preoperative Risk Assessment 
Anamnesis and physical examination are the keystones of 
the preoperative risk assessment. Measurement of oxygen 
saturation by a pulse oximeter is beneficial in assessing the 
risk before high-risk surgical interventions. Laboratory tests 
that could be requested in the preoperative period include 
pulmonary function test, arterial blood gases, and chest x-ray 
[67]. Criteria that are suggestive of enhanced risk in the pre-
operative period include [68] FEV1 <70% (of the predicted 
value), FVC <70% (of the predicted value), and FEV1/FVC 
<65% (of the predicted value). It has been emphasized that 
the risk of postoperative pulmonary complications is high in 
patients with PaCO2 >45 mm Hg [69]. 
Upper respiratory tract infections: In patients with a body tem-
perature >38.5°C, purulent nasal discharge, and symptoms of a 
lower respiratory tract infection (productive cough, rales, rhon-
chi, and positive chest x-ray finding), surgery should be post-
poned for 4-6 weeks until the disappearance of symptoms [70]. 
Asthma: Frequent use of bronchodilators, acute asthma 
attacks in recent times, and hospital admissions pose impor-
tant risks for perioperative bronchospasm. The primary goal 
in an asthmatic patient is to perform the surgical procedure 
during the asymptomatic period [71]. The patient has to be 
free of wheezing, and peak expiratory flow should be at the 
best personal value or higher than 80% of the predicted 
value before surgery [72]. An inhaled beta-2 adrenergic ago-
nist can be used 1-2 hours before the surgery in patients with 
controlled asthma. Inhaled corticosteroid and regular use of 
inhaled beta-2 agonists 1 week before the surgery are appro-
priate in patients with moderately controlled asthma. In 
patients with poorly controlled asthma, one of the following 
should be added to the treatment that is given to patients 
with moderately controlled asthma: oral prednisone (1 mg/
kg/day, maximum dose: 60 mg/day) or oral dexamethasone 
(0.6 mg/kg/day, maximum dose: 16 mg/day) 3-5 days before 
surgery or oral methylprednisolone (1 mg/kg/day) for 2 days 
before surgery [73]. 
Bronchopulmonary Dysplasia: Room air oxygen saturation, 
PaCO2, blood gas, baseline oxygenation, and acid/base bal-
ance should be analyzed. The probability of pulmonary 
hypertension should be kept in mind, and electrocardiogra-
phy and an echocardiographic examination should be 
requested when necessary [74]. BPD patients with airway 
hyperactivity may benefit from short-acting beta-2 agonists 
given 1-2 hours before the induction of anesthesia. 
Obstructive sleep apnea syndrome: In the preoperative 
period, serum electrolytes, blood gases (high bicarbonate 
levels may be encountered as a metabolic response to 
chronic hypercarbia), room air oxygen saturation measured 
by a pulse oximeter, and hematocrit level (hematocrit levels 
may be elevated as a response to chronic hypoxia) should be 
analyzed in such children [75]. 
Cystic Fibrosis: In the preoperative period, chest x-ray, pul-
monary function test, blood glucose, sputum culture and 
antibiogram, hepatic function tests, serum electrolyte levels, 
and complete blood count should be requested [76]. If 
needed, coagulation tests, blood gases, and an echocardio-
graphic examination should be considered. Signs of active 
infection in the preoperative period necessitate hospitaliza-
tion and preoperative intensive pulmonary treatment [77]. 
Neuromuscular Diseases: Oxygen saturation (pulse oxime-
ter), blood gas (PaCO2), respiratory function test (the risk 
increases if FVC is <50%), and echocardiography should be 
requested [78,79]. Education on non-invasive mechanical 
ventilation should be given to patients with a risk of 
hypoventilation in the preoperative period, and education on 
the mechanical insufflation-exsufflation device should be 
given to patients who can not cough effectively [79,80]. 
Primary Ciliary Dyskinesia: In the preoperative preparation 
of primary ciliary dyskinesia, the active pulmonary infection 
is treated, and the presence of any organ inversion (inverted 
location) is investigated [73]. 
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